Posterity Health delivers comprehensive male reproductive and hormonal healthcare via telehealth, at-home diagnostics, and in-person services, covering fertility optimization, hormone management, vasectomies, and related procedures. Its platform uses technology-driven triage and decision-support tools to match patients with reproductive urologists and guide appropriate testosterone therapy. The company emphasizes early male evaluation to reduce unnecessary female treatments and to detect underlying health risks linked to male infertility. Posterity cites an actuarial analysis showing employers save $2.30 for every $1 spent on male fertility care and notes that 50% of infertility cases are linked to the male partner. The company is expanding nationwide and building a growing team of reproductive urologists. Dr. William Schoolcraft joined as a strategic advisor to support clinician and public education on early male fertility evaluation. Posterity Health is the only digital male fertility center of excellence offering personalized advice, educational resources, and effective male fertility treatments. Its Digital Health Platform combines virtual visits, at-home diagnostics, and in-person consultations and delivers services including baseline assessments, sperm preservation, semen analysis, pregnancy loss consults, diagnostic workups, vasectomy reversals, and gender-affirming care. The company deploys care protocols developed with a Medical Advisory Board that includes leaders from Weill Cornell, UCSF, and Yale. Posterity plans to use the $7.5M oversubscribed round to accelerate its Digital Health Platform and expand national access to male fertility testing and treatment, doubling the number of reproductive urologists on its network. The expansion is timed to capitalize on new male fertility benefits that became effective January 1, 2023. Early data from a hormone management study showed nearly 70 percent of males receiving hormone management therapy had an improved sperm count, which the company cites as validation of its care model. Posterity Health operates a digital male fertility platform that provides personalized advice, educational resources, and treatments aimed at addressing male contributors to infertility. Its telehealth offering, Male Factor Management, delivers virtual visits, at-home diagnostics, and in-person consults. Services include baseline assessments, sperm preservation, semen analysis, pregnancy loss consults, diagnostic workups, vasectomy reversals, and gender-affirming care. The company emphasizes education and engagement through its digital platform combined with at-home testing as a key differentiator. Posterity launched service in Colorado, currently provides care in 26 states, and has a team of 15 people. Founders Pam Pure (CEO) and Barrett Cowan (co-founder and CMO) plan to grow the clinical team and partnerships while expanding services nationwide.

Total raised

$27M

Funding rounds

3

Latest round

Series A

Latest activity

Feb 2025